Essential Takeaways
- We’re thrilled to announce that our gold standard clinical study has been published in Frontiers in Nutrition—a leading, internationally recognized, peer-reviewed journal. Being published is the final step to ensuring quality research, and often the most difficult one to achieve.
- We sat down with Ritual’s VP of Scientific Affairs, Dr. Mastaneh Sharafi, PhD, RD, to shed some light into what this milestone means—for our customers, our company, and the scientific community at large.
From the start, our MadeTraceable™ mission has been non-negotiable, and our POV clear: Knowing what you’re putting into your body (and why) should be a given, more necessity than a “nice-to-have.”
That said, as skeptics, we don’t just want you to take us at our word—we’re committed to showing you the receipts along the way. One part of that is building a clinical-backed future, which is why our first clinical trial quantifying the impact of Essential for Women 18+ was such a huge deal.
And it paid off: The results from our 12-week clinical trial—conducted as a double-blind, placebo-controlled trial in partnership with Auburn University, on 94 women ages 21 through 40—were significant, with Essential for Women 18+ increasing vitamin D3 levels by 43% and omega-3 DHA levels by 41% in just 12 weeks.*
With that, we’re thrilled to share another huge milestone: Our gold standard clinical study has been published in Frontiers in Nutrition—a leading, internationally recognized, peer-reviewed journal.
To be clear, having a study published in a peer-reviewed journal is one of the highest awards scientific research can achieve—it means our study was put through the quality control ringer; everything from the design and implementation to the analysis and accuracy of our results was carefully evaluated and accepted by reviewers.